Protein Therapeutics Maxygen is a leader in the optimization and modification of protein pharmaceuticals. We have assembled a series of technologies that make it possible to improve specific properties of protein pharmaceuticals that have not been possible using traditional methods. >> Vaccines Under a contract and grants from the National Institutes of Health (NIH) and the United States Department of Defense Maxygen is working to advance research for development of a prophylactic vaccine for HIV. >> A Robust Pipeline We are currently working a broad portfolio of next generation therapeutic proteins that are designed to address significant unmet medical needs and large market opportunities. >>